Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Division of Infectious Diseases & Infection Control Program, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
J Antimicrob Chemother. 2017 Oct 1;72(10):2910-2914. doi: 10.1093/jac/dkx243.
A variety of indicators is commonly used to monitor antibiotic prescriptions as part of national antimicrobial stewardship (AMS) programmes.
To make an inventory of indicators that assess antibiotic prescriptions and are linked to specific targets and incentives, at a national level.
A cross-sectional survey (three-item questionnaire) was conducted in 2017 among all ESGAP (ESCMID Study Group for Antimicrobial stewardshiP) members, coming from 23 European countries and 16 non-European countries.
Almost all (20/23, 87%) European countries belonging to the ESGAP network participated, as well as one non-European country. Computerized systems routinely linking antibiotic prescriptions to clinical diagnoses were reported for only two countries (Turkey and Croatia). Only 6/21 (29%) countries had national indicators with both clear targets and incentives (Bulgaria, Croatia, France, the Netherlands, Norway and Portugal). We identified a total of 21 different indicators used in these countries, 16 concerning inpatients (9 quality indicators and 7 quantity metrics) and 8 concerning outpatients (all quantity metrics); some indicators were used in both settings. Three types of incentives were used: financing mechanism, hospitals' accreditation and public reporting. Some respondents reported that such indicators with both clear targets and incentives were used at a regional level in their country (e.g. Andalusia in Spain and England in the UK).
National indicators, with clear targets and incentives, are not commonly used in Europe and we observed wide variations between countries regarding the selected indicators, the units of measure and the chosen targets.
作为国家抗菌药物管理(AMS)计划的一部分,通常使用多种指标来监测抗生素处方。
列出评估抗生素处方并与特定目标和激励措施相关的指标,以评估国家层面的情况。
2017 年,对来自 23 个欧洲国家和 16 个非欧洲国家的所有 ESGAP(ESCMID 抗菌药物管理研究小组)成员进行了横断面调查(三项目问卷调查)。
几乎所有(23 个中的 20 个,87%)属于 ESGAP 网络的欧洲国家以及一个非欧洲国家都参与了调查。只有两个国家(土耳其和克罗地亚)报告了将抗生素处方与临床诊断常规联系起来的计算机系统。只有 6/21(29%)个国家有既有明确目标又有激励措施的国家指标(保加利亚、克罗地亚、法国、荷兰、挪威和葡萄牙)。我们在这些国家共确定了 21 种不同的指标,16 种用于住院患者(9 种质量指标和 7 种数量指标),8 种用于门诊患者(均为数量指标);有些指标同时用于两种情况。使用了三种类型的激励措施:融资机制、医院认证和公共报告。一些受访者报告说,在他们的国家,这种既有明确目标又有激励措施的指标是在地区层面使用的(例如西班牙的安达卢西亚和英国的英格兰)。
在欧洲,没有明确目标和激励措施的国家指标并不常用,而且我们观察到各国之间在选择的指标、度量单位和选择的目标方面存在很大差异。